CARIBOU BIOSCIENCES INC. - COMMON STOCK

Caribou Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update

09 8月 2022 13:00:00 条件 Nasdaq GlobeNewswire

Caribou Biosciences Reports Positive Additional Data from CB-010 Allogeneic CAR-T Cell Therapy Phase 1 ANTLER Trial at the European Hematology Association (EHA) 2022 Hybrid Congress

10 6月 2022 00:00:00 条件 Nasdaq GlobeNewswire

Caribou Biosciences Announces Webcast Conference Call to Highlight Initial CB-010 ANTLER Phase 1 Data Presentation at EHA on June 10, 2022

01 6月 2022 13:05:00 条件 Nasdaq GlobeNewswire

Caribou Biosciences Presents Data on Mechanism Underlying Superior Specificity of Caribou’s chRDNA Genome-Editing Technology in Primary Human T cells

16 5月 2022 13:05:01 条件 Nasdaq GlobeNewswire

Caribou Biosciences Announces Positive Initial Data for CB-010 Anti-CD19 Allogeneic CAR-T Cell Therapy

12 5月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Caribou Biosciences Announces Appointment of David Johnson to its Board of Directors

11 5月 2022 13:00:00 条件 Nasdaq GlobeNewswire

Caribou Biosciences Reports First Quarter 2022 Financial Results and Provides Business Updates

09 5月 2022 13:05:01 条件 Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conference

03 5月 2022 13:05:00 条件 Nasdaq GlobeNewswire

Caribou Biosciences to Share CB-010 Initial Clinical Data at the Upcoming European Hematology Association (EHA) 2022 Hybrid Congress

25 4月 2022 13:05:00 条件 Nasdaq GlobeNewswire

Caribou Biosciences Presents Positive Preclinical Data for Allogeneic Anti-BCMA CAR-T Cell Therapy Candidate CB-011 at the American Association for Cancer Research (AACR) Annual Meeting

08 4月 2022 10:07:17 条件 Nasdaq GlobeNewswire

Caribou Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

21 3月 2022 13:02:00 条件 Nasdaq GlobeNewswire

Caribou Biosciences to Present Preclinical Data on CB-011, an Immune-Cloaked Allogeneic Anti-BCMA CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting

08 3月 2022 17:19:17 条件 Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

07 3月 2022 13:10:57 条件 Nasdaq GlobeNewswire

Caribou Biosciences to Present at the SVB Leerink 11th Annual Global Healthcare Conference

07 2月 2022 13:05:00 条件 Nasdaq GlobeNewswire

Caribou Biosciences Appoints Syed Rizvi, M.D., as Chief Medical Officer

18 1月 2022 05:00:02 条件 Nasdaq GlobeNewswire

Caribou Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference

04 1月 2022 13:05:00 条件 Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

17 11月 2021 13:05:00 条件 Nasdaq GlobeNewswire

Caribou Biosciences Provides Business Update and Reports Third Quarter 2021 Financial Results

09 11月 2021 13:05:03 条件 Nasdaq GlobeNewswire

Caribou Biosciences Appoints Dara Richardson-Heron, M.D., to its Board of Directors and Ruhi Khan as Chief Business Officer

08 11月 2021 06:00:00 条件 Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

20 10月 2021 13:00:00 条件 Nasdaq GlobeNewswire